Risk of infections in bispecific antibody therapy for multiple myeloma: a comprehensive review of literature
Multiple Myeloma (MM) is a malignancy characterized by abnormal production of monoclonal immunoglobulins in plasma cells. Bispecific antibodies have emerged as a significant advancement in MM treatment, offering high effectiveness and specificity by targeting different antigens such as BCMA, CD38, a...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2025-12-01
|
| Serie: | Hematology |
| Soggetti: | |
| Accesso online: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2448898 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|